An HbA1c of 5.7 indicates years of insulin resistance and metabolic damage, says Dr Gagandeep, suggesting pre-diabetes is an ...
LONDON, Nov. 14, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced the continued commercial expansion of its HbA1c test, for ...
Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...